Advances in ophthalmology practice and research最新文献

筛选
英文 中文
Global, regional, and national trends in glaucoma burden among adults aged 45 years and older, 1990-2021 1990-2021年全球、区域和国家45岁及以上成人青光眼负担趋势
IF 4.5
Advances in ophthalmology practice and research Pub Date : 2026-11-01 Epub Date: 2026-06-20 DOI: 10.1016/j.aopr.2026.06.004
Chao Wu, Fan Cao, Baorui Chu, Xianyang Liu, Shuhao Zeng, Yakun Wang, Hui Feng, Xinyuan Chen, Ningli Wang, Shengping Hou
{"title":"Global, regional, and national trends in glaucoma burden among adults aged 45 years and older, 1990-2021","authors":"Chao Wu,&nbsp;Fan Cao,&nbsp;Baorui Chu,&nbsp;Xianyang Liu,&nbsp;Shuhao Zeng,&nbsp;Yakun Wang,&nbsp;Hui Feng,&nbsp;Xinyuan Chen,&nbsp;Ningli Wang,&nbsp;Shengping Hou","doi":"10.1016/j.aopr.2026.06.004","DOIUrl":"10.1016/j.aopr.2026.06.004","url":null,"abstract":"<div><h3>Purpose</h3><div>Glaucoma is the leading cause of irreversible blindness worldwide. This study aimed to assess global, regional, and national trends in glaucoma burden among adults aged ≥45 years from 1990 to 2021.</div></div><div><h3>Methods</h3><div>Data were obtained from the Global Burden of Disease 2021 study. Prevalence and disability-adjusted life-years (DALYs) for glaucoma were analyzed by age, sex, region, and Sociodemographic Index (SDI). Joinpoint regression identified trend changes, and frontier analysis benchmarked country-level performance.</div></div><div><h3>Results</h3><div>Globally, age-standardized prevalence declined from 116.29 to 90.12 per 100 000 (average annual percentage change, AAPC = −0.82), and DALYs from 13.37 to 9.05 (AAPC = −1.24), while absolute cases increased by 86.33% due to population aging. Five significant trend changes were identified (1994, 2001, 2006, 2010, 2019). The largest prevalence reduction was in adults aged 90–94 years. East Asia experienced the most substantial declines. SDI showed a strong negative correlation with glaucoma burden. Sub-Saharan Africa had the highest burden, while high-SDI regions had the lowest.</div></div><div><h3>Conclusion<em>s</em></h3><div>Global age-standardized prevalence and DALYs for glaucoma declined between 1990 and 2021, with accelerated declines temporally coinciding with key therapeutic advances. The absolute number of affected individuals increased due to population aging, underscoring the need for targeted screening programs and public awareness campaigns emphasizing regular eye examinations for early detection.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"6 4","pages":"Pages 363-372"},"PeriodicalIF":4.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149350529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical efficacy of topical 0.1% tacrolimus in patients with corneal neovascularization: A prospective, multicenter, randomized controlled pilot trial 局部应用0.1%他克莫司治疗角膜新生血管患者的临床疗效:一项前瞻性、多中心、随机对照先导试验
IF 4.5
Advances in ophthalmology practice and research Pub Date : 2026-11-01 Epub Date: 2026-08-05 DOI: 10.1016/j.aopr.2026.08.001
Myung-Sun Song, Youngsub Eom, Ikhyun Jun, Hun Lee
{"title":"Clinical efficacy of topical 0.1% tacrolimus in patients with corneal neovascularization: A prospective, multicenter, randomized controlled pilot trial","authors":"Myung-Sun Song,&nbsp;Youngsub Eom,&nbsp;Ikhyun Jun,&nbsp;Hun Lee","doi":"10.1016/j.aopr.2026.08.001","DOIUrl":"10.1016/j.aopr.2026.08.001","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the effect of topical 0.1% tacrolimus on corneal neovascularization (CoNV) and compare its efficacy with 1% prednisolone acetate.</div></div><div><h3>Methods</h3><div>In this prospective, multicenter, evaluator-masked, randomized study, patients with CoNV were randomized to 0.1% tacrolimus or 1% prednisolone acetate. Eye drops were administered four times daily for 4 weeks, then twice daily for an additional 4 weeks. Clinical assessments included CoNV grade, visual acuity, intraocular pressure, and ocular surface staining scores. A linear mixed model was used to evaluate treatment effects.</div></div><div><h3>Results</h3><div>Forty-six patients (tacrolimus group, n = 24; prednisolone group, n = 22) were analyzed. Most baseline characteristics were comparable between groups, except for endothelial cell density, which was significantly lower in the tacrolimus group (<em>P</em> = 0.040). In both groups, CoNV grade decreased significantly from baseline to week 4 (tacrolimus group: 2.025 ± 0.162 to 1.733 ± 0.162, <em>P</em> = 0.003; prednisolone group: 1.852 ± 0.168 to 1.625 ± 0.168, <em>P</em> = 0.035), with no significant between-group difference (<em>P</em> = 0.688). No significant change in CoNV grade was observed from week 4 to week 8 in either group. Over the 8-week period, significant within-group decrease in CoNV grade was observed in the tacrolimus group only (2.025 ± 0.162 to 1.697 ± 0.164, <em>P</em> = 0.019).</div></div><div><h3>Conclusions</h3><div>Both 0.1% tacrolimus and 1% prednisolone acetate reduced CoNV during the first 4 weeks. The sustained reduction in CoNV through 8 weeks in the tacrolimus group suggests its potential as an alternative or adjunctive therapy for CoNV, warranting further investigation.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"6 4","pages":"Pages 373-378"},"PeriodicalIF":4.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149350530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Central-field stimulus thresholds in age-related macular degeneration: Associations with visual function and retinal structure 老年性黄斑变性的中央野刺激阈值:与视觉功能和视网膜结构的关系。
IF 4.5
Advances in ophthalmology practice and research Pub Date : 2026-11-01 Epub Date: 2026-07-01 DOI: 10.1016/j.aopr.2026.06.005
Yuhong Chen, Qiyu Bo, Wenjia Liu, Hong Wang, Zishi Liu, Haoliang Zhang, Jieqiong Chen, Junran Sun, Huixun Jia, Yuanyuan Gong, Tong Li, Xiaodong Sun
{"title":"Central-field stimulus thresholds in age-related macular degeneration: Associations with visual function and retinal structure","authors":"Yuhong Chen,&nbsp;Qiyu Bo,&nbsp;Wenjia Liu,&nbsp;Hong Wang,&nbsp;Zishi Liu,&nbsp;Haoliang Zhang,&nbsp;Jieqiong Chen,&nbsp;Junran Sun,&nbsp;Huixun Jia,&nbsp;Yuanyuan Gong,&nbsp;Tong Li,&nbsp;Xiaodong Sun","doi":"10.1016/j.aopr.2026.06.005","DOIUrl":"10.1016/j.aopr.2026.06.005","url":null,"abstract":"<div><h3>Background</h3><div>To evaluate the central-field stimulus threshold (CST) values in patients with age-related macular degeneration (AMD) and investigate the relationship between CST values and conventional visual function assessments, as well as retinal anatomical parameters, thereby exploring the role of CST in assessing anti-vascular endothelial growth factor (VEGF) therapy.</div></div><div><h3>Methods</h3><div>Forty patients (eighty eyes) with AMD were included in the analysis. All patients underwent complete ophthalmic examination, including slit-lamp examination, fundus examination, intraocular pressure measurement, Early Treatment Diabetic Retinopathy Study best-corrected visual acuity (BCVA), fundus photography, optical coherence tomography (OCT), OCT angiography, microperimetry (MP), and CST testing. Linear mixed-effects models and generalized linear mixed models were employed to analyze the correlations between CST and BCVA, MP, OCT features, and choroidal neovascularization (CNV) area, as well as changes in CST following anti-VEGF therapy.</div></div><div><h3>Results</h3><div>Compared to normal eyes, neovascular AMD (nAMD) eyes exhibited higher CST values for white (−47.02 ± 9.02 vs. −51.09 ± 3.61 dB), blue (−52.50 ± 14.46 vs. −60.28 ± 8.60 dB), and red (−30.22 ± 8.21 vs. −36.24 ± 6.41 dB) stimuli. Approximately 39% of nAMD eyes exhibited cone-mediated vision under scotopic conditions. In nAMD eyes, BCVA was negatively correlated with blue and white CST, indicating that better BCVA was associated with higher central retinal light sensitivity. Red and blue CST were positively correlated with center retinal thickness (CRT) and CNV area (All <em>P</em> &lt; 0.05). In the thicker CRT group, the blue-red CST difference decreased from −18.03 ± 10.01 dB to −22.85 ± 2.22 dB after 1 month of anti-VEGF treatment (<em>P</em> = 0.047), 9 of 14 eyes were cone-mediated at baseline, which decreased to 3 eyes after three months of treatment.</div></div><div><h3>Conclusions</h3><div>CST assessment revealed that both cone and rod were affected in nAMD eyes. CST was correlated with CRT and CNV area. In some nAMD patients, severe rod dysfunction leads to a shift to cone-mediated vision under scotopic conditions, but anti-VEGF therapy may ameliorate this phenomenon. These findings suggest that CST assesses the visual function of AMD patients from a more microscopic, cellular functional standpoint, which may be beneficial for monitoring AMD progression and evaluating the treatment efficacy.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"6 4","pages":"Pages 355-362"},"PeriodicalIF":4.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13735234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149344863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anterior chamber depth and vitreous zonule integrity as biomarkers for intraoperative capsule laxity in angle closure 前房深度和玻璃体带完整性作为术中闭角术中囊松弛度的生物标志物
IF 4.5
Advances in ophthalmology practice and research Pub Date : 2026-08-01 Epub Date: 2026-05-01 DOI: 10.1016/j.aopr.2026.04.002
Hui Zhang, Jin Wang, Yue Wang, Zijian Liu, Dongjun Li, Lin Shen, Chunyan Qiao, Ching-Yu Cheng, Ye Zhang
{"title":"Anterior chamber depth and vitreous zonule integrity as biomarkers for intraoperative capsule laxity in angle closure","authors":"Hui Zhang,&nbsp;Jin Wang,&nbsp;Yue Wang,&nbsp;Zijian Liu,&nbsp;Dongjun Li,&nbsp;Lin Shen,&nbsp;Chunyan Qiao,&nbsp;Ching-Yu Cheng,&nbsp;Ye Zhang","doi":"10.1016/j.aopr.2026.04.002","DOIUrl":"10.1016/j.aopr.2026.04.002","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate preoperative predictors for anterior and posterior capsule laxity during phacoemulsification combined with anti-glaucoma surgery in eyes with angle closure.</div></div><div><h3>Methods</h3><div>Cross-sectional study. Patients aged ≥40 years diagnosed with angle closure who underwent phacoemulsification combined with anti-glaucoma surgery between May 2023 and May 2025 were enrolled. Eyes were classified into four groups based on intraoperative findings: anterior capsule laxity, posterior capsule laxity, combined capsule laxity, and normal capsule. Mixed-effects logistic regression analysis was employed to determine the independent predictors of anterior and posterior capsule laxity, respectively.</div></div><div><h3>Results</h3><div>A total of 241 eyes of 203 patients were included. 36 eyes (14.9%) had anterior laxity, 51 eyes (21.2%) had posterior laxity, 73 eyes (30.3%) had combined capsule laxity, and 81 eyes (33.6%) had normal capsule. Eyes with anterior laxity had shallower anterior chamber depth (ACD) than normal capsule eyes (2.05 (1.82,2.29) mm vs. 2.33 (2.13, 2.52) mm, <em>P</em>&lt;0.001) and were more frequently acute primary angle closure (APAC) (<em>P</em>=0.001). Posterior/combined laxity eyes showed higher vitreous zonule (VZ) absence (both <em>P</em>&lt;0.001); combined laxity having thicker lens than normal eyes (5.16 ± 0.35mm vs. 4.95 ± 0.43mm, <em>P</em>=0.006). Regression analysis identified APAC diagnosis (odds ratio (OR) 3.04, 95% confidence interval (CI): 1.01–9.38, <em>P</em>=0.049) and shallower ACD (OR 0.05, 95% CI: 0.01–0.26, <em>P</em>=0.001) as independent predictors for anterior capsule laxity, while APAC diagnosis (OR 3.89, 95% CI: 1.20–13.50, <em>P</em>=0.026), VZ absence (OR 0.11, 95% CI: 0.04–0.27, <em>P</em>&lt;0.001), and increased ciliary body maximum thickness (CBMT) (OR 1.92, 95% CI: 1.22–3.17, <em>P</em>=0.007) predicted posterior capsule laxity. The anterior and posterior capsule laxity prediction models achieved AUC values of 0.817 (95% CI: 0.739–0.896) and 0.781 (95% CI: 0.690–0.872), respectively.</div></div><div><h3>Conclusions</h3><div>APAC diagnosis and shallow ACD predict anterior capsule laxity, whilst VZ absence, APAC diagnosis, and increased CBMT indicate posterior capsule laxity in eyes with angle closure. Identification of these biomarkers before surgery may help surgeons anticipate complications and optimize postoperative outcomes.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"6 3","pages":"Pages 257-265"},"PeriodicalIF":4.5,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148730402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating large language model clinical reasoning in glaucoma using retrieval-augmented generation 利用检索增强生成评价青光眼的大语言模型临床推理
IF 4.5
Advances in ophthalmology practice and research Pub Date : 2026-08-01 Epub Date: 2026-05-26 DOI: 10.1016/j.aopr.2026.05.003
Houfa Yin, Qi Miao, Wanshu Zhou, Chenyang Hu, Yongwei Guo, Lixia Shen, Haiyan Cai, Andrzej Grzybowski, Kai Jin
{"title":"Evaluating large language model clinical reasoning in glaucoma using retrieval-augmented generation","authors":"Houfa Yin,&nbsp;Qi Miao,&nbsp;Wanshu Zhou,&nbsp;Chenyang Hu,&nbsp;Yongwei Guo,&nbsp;Lixia Shen,&nbsp;Haiyan Cai,&nbsp;Andrzej Grzybowski,&nbsp;Kai Jin","doi":"10.1016/j.aopr.2026.05.003","DOIUrl":"10.1016/j.aopr.2026.05.003","url":null,"abstract":"<div><h3>Background</h3><div>Large language models (LLMs) demonstrate strong performance in knowledge-based medical tasks, yet their clinical reasoning capabilities in complex ophthalmic decision-making, particularly glaucoma management, remain insufficiently characterized. Retrieval-augmented generation (RAG) has been proposed as a strategy to improve factual grounding and safety, but its clinical value requires systematic evaluation.</div></div><div><h3>Methods</h3><div>We conducted a retrospective, scenario-based comparative evaluation using 40 real-world glaucoma cases spanning primary, secondary, postoperative, and end-stage disease. Six model conditions (GPT, Gemini, and Grok, each with and without RAG) were assessed using a guideline-grounded framework covering medical accuracy, key point coverage, logical completeness, and a separate qualitative safety audit. Model outputs were compared with written responses from four practicing ophthalmologists. All responses were independently scored by two masked glaucoma specialists using a prespecified ordinal rubric, and formal inter-rater reliability and paired sensitivity analyses were performed.</div></div><div><h3>Results</h3><div>RAG-enhanced models consistently outperformed their matched non-RAG counterparts across evaluation domains. In human-rating sensitivity analyses, the composite RAG advantage remained significant for GPT (mean difference=0.119, 95% CI: 0.068–0.173), Gemini (mean difference=0.095, 95% CI: 0.030–0.161), and Grok (mean difference=0.110, 95% CI: 0.033–0.194). Inter-rater agreement of the ordinal rubric was limited, supporting consensus adjudication and cautious interpretation of artificial intelligence-human comparisons.</div></div><div><h3>Conclusions</h3><div>Retrieval augmentation was associated with more accurate, more complete, and more safety-aware glaucoma reasoning under this scenario-based evaluation. These findings support the potential value of RAG-enhanced LLMs as supervised clinical decision-support tools, but they do not establish standalone clinical use. Safety was evaluated as a separate audit layer rather than as part of the weighted composite score.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"6 3","pages":"Pages 291-298"},"PeriodicalIF":4.5,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148770817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A practical starting guide to tear fluid biobanking 泪液生物库的实用入门指南
IF 4.5
Advances in ophthalmology practice and research Pub Date : 2026-08-01 Epub Date: 2026-04-27 DOI: 10.1016/j.aopr.2026.04.001
Jente Schmeetz, Suzanne Hagan, Nienke van de Sande, Nikolay Boychev, Karima Kessal, Marlies Gijs
{"title":"A practical starting guide to tear fluid biobanking","authors":"Jente Schmeetz,&nbsp;Suzanne Hagan,&nbsp;Nienke van de Sande,&nbsp;Nikolay Boychev,&nbsp;Karima Kessal,&nbsp;Marlies Gijs","doi":"10.1016/j.aopr.2026.04.001","DOIUrl":"10.1016/j.aopr.2026.04.001","url":null,"abstract":"<div><h3>Background</h3><div>Tear fluid is increasingly recognized as a minimally invasive source of biomarkers in various diseases with broad potential for diagnostics and disease monitoring. Biobanking tear fluid samples provides valuable access to high-quality biological samples while reducing the need for new collection efforts. Ensuring appropriate collection and storage conditions is critical for maintaining sample integrity. However, standardized guidelines and operating protocols for tear fluid biobanking are still lacking.</div></div><div><h3>Main text</h3><div>This review synthesizes existing literature on tear fluid biobanking, complemented by additional sources such as reports and online guidelines on biobanking standards and recommendations. Together, these insights provide a practical guide for researchers and institutions aiming to establish a tear fluid biobank or integrate tear fluid samples into existing biobanking infrastructures. This guide outlines key aspects including (i) governance, regulatory, and ethical considerations, (ii) biosafety, infrastructure, and logistics, (iii) collection methods and materials, and (iv) data harmonization through the developed and proposed Tear Fluid-Common Data Elements, which emphasize on the collection, storage, processing, and analysis of biobanked samples.</div></div><div><h3>Conclusions</h3><div>By providing clear and practical guidance, this review supports the standardization of tear fluid biobanking, thereby enhancing the value of these samples for future research and clinical applications.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"6 3","pages":"Pages 281-290"},"PeriodicalIF":4.5,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148770820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterizing the non-pigmented retinitis pigmentosa in a Chinese cohort: Insights into phenotype, genotype, and disease progression 表征中国队列中的非色素视网膜色素变性:对表型、基因型和疾病进展的见解
IF 4.5
Advances in ophthalmology practice and research Pub Date : 2026-08-01 Epub Date: 2026-02-28 DOI: 10.1016/j.aopr.2026.02.005
Hong-Li Liu, Ping Xu, Sheng-Hai Zhang, Wei Liu, Ji-Hong Wu
{"title":"Characterizing the non-pigmented retinitis pigmentosa in a Chinese cohort: Insights into phenotype, genotype, and disease progression","authors":"Hong-Li Liu,&nbsp;Ping Xu,&nbsp;Sheng-Hai Zhang,&nbsp;Wei Liu,&nbsp;Ji-Hong Wu","doi":"10.1016/j.aopr.2026.02.005","DOIUrl":"10.1016/j.aopr.2026.02.005","url":null,"abstract":"<div><h3>Purpose<em>s</em></h3><div>To characterize the comprehensive clinical and genetic spectrum of non-pigmented presentation of retinitis pigmentosa in a large Chinese cohort, addressing a significant knowledge gap in non-Caucasian populations.</div></div><div><h3>Methods</h3><div>This retrospective, cross-sectional study identified and characterized 80 patients with an absence of typical pigmentation from a cohort of 1063 individuals with retinitis pigmentosa at a single tertiary center.</div></div><div><h3>Results</h3><div>A proportion of 7.5% of the retinitis pigmentosa patients in our clinic-based cohort presented with the non-pigmented phenotype. This subgroup was characterized by a myopic shift (median spherical power: −1.00 D) and a distinct superior-to-inferior gradient of visual field defect. Survival analysis identified a critical window of accelerated functional decline between ages 34.5 and 52. Visual acuity decline was biphasic, with rates peaking within the first 5 years (0.044 logMAR/year) and after 40 years of disease (0.079 logMAR/year). Age significantly amplified the detrimental effect of disease duration on vision (<em>β</em> = 0.015 vs. 0.008 logMAR/year in older vs. younger patients). Structurally, horizontal ellipsoid zone width was a key biomarker. A definitive genetic diagnosis was achieved in 41.3% (33/80) of patients, most frequently <em>EYS</em> and <em>USH2A</em>. Genotype-phenotype correlations revealed that large structural deletions and truncating variants were significantly associated with ultra-early onset and more severe visual impairment, respectively.</div></div><div><h3>Conclusions</h3><div>This study characterizes the non-pigmented presentation within the retinitis pigmentosa disease spectrum, detailing its phenotypic characteristics and natural history. The identified clinical, structural, and genetic biomarkers enable refined prognosis and inform stratified therapeutic trials.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"6 3","pages":"Pages 299-307"},"PeriodicalIF":4.5,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148770819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A meta-analysis of clinical outcomes in diabetic macular edema 糖尿病性黄斑水肿临床结果的荟萃分析
IF 4.5
Advances in ophthalmology practice and research Pub Date : 2026-08-01 Epub Date: 2026-06-10 DOI: 10.1016/j.aopr.2026.06.001
Christina N. Bobrek, Ishani Kapoor, Swara M. Sarvepalli, Elise Timtim, Majda Hadziahmetovic
{"title":"A meta-analysis of clinical outcomes in diabetic macular edema","authors":"Christina N. Bobrek,&nbsp;Ishani Kapoor,&nbsp;Swara M. Sarvepalli,&nbsp;Elise Timtim,&nbsp;Majda Hadziahmetovic","doi":"10.1016/j.aopr.2026.06.001","DOIUrl":"10.1016/j.aopr.2026.06.001","url":null,"abstract":"<div><h3>Objective</h3><div>To compare the efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF), steroid, and laser on best-corrected visual acuity (BCVA), central retinal thickness (CRT), and treatment frequency in patients with diabetic macular edema.</div></div><div><h3>Methods</h3><div>PubMed, EMBASE, and Web of Science were systematically searched from inception to August 2024. Mean change from baseline in BCVA (mcBCVA), mean change from baseline in CRT (mcCRT), and treatment frequency were collected using PRISMA guidelines. Statistical analysis was done on 20 studies using Review Manager 5.4.1.</div></div><div><h3>Results</h3><div>mcBCVA (mean difference (MD) = 0.14 logMAR, 95% confidence interval (CI): 0.05 to 0.23, <em>P</em> = 0.002) and mcCRT (MD = 38.73 μm, 95% CI: 13.39 to 64.08, <em>P</em> = 0.003) were significantly improved in the anti-VEGF group compared to laser. mcCRT (MD = −61.17 μm, 95% CI: −106.07 to −16.27, <em>P</em> = 0.008) was significantly greater in the steroid group compared to anti-VEGF. Mean number of treatments per year was significantly lower in the steroid treatment group compared to anti-VEGF (MD = −4.29, 95% CI: −4.5 to −4.09, <em>P</em> &lt; 0.00001). In the anti-VEGF subgroup, mcCRT was significantly greater in the aflibercept group (MD = −37.52 μm, 95% CI: −62.97 to −12.07, <em>P</em> = 0.004) when compared to bevacizumab.</div></div><div><h3>Conclusions</h3><div>These data suggest anti-VEGF treatment is more effective than laser at improving BCVA and CRT, whereas steroid treatment is more effective than anti-VEGF at improving CRT outcomes. Steroid therapy, while not currently allotted a first-line therapy in the United States, may have a more significant role in reducing treatment burden and improving macular morphology.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"6 3","pages":"Pages 266-272"},"PeriodicalIF":4.5,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148770818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fifteen-year follow-up of implantable collamer lens surgery in high myopia: Complications, cataract surgery outcomes, and ultrastructural analysis 高度近视植入式晶状体手术15年随访:并发症、白内障手术结果及超微结构分析
IF 4.5
Advances in ophthalmology practice and research Pub Date : 2026-08-01 Epub Date: 2026-03-13 DOI: 10.1016/j.aopr.2026.02.001
Yinjie Jiang, Guanghan Xu, I-Chun Lin, Mingrui Cheng, Boliang Li, Yadi Lei, Mingwei Li, Zhiwei Mao, Rui Ning, Xun Chen, Xiaoying Wang
{"title":"Fifteen-year follow-up of implantable collamer lens surgery in high myopia: Complications, cataract surgery outcomes, and ultrastructural analysis","authors":"Yinjie Jiang,&nbsp;Guanghan Xu,&nbsp;I-Chun Lin,&nbsp;Mingrui Cheng,&nbsp;Boliang Li,&nbsp;Yadi Lei,&nbsp;Mingwei Li,&nbsp;Zhiwei Mao,&nbsp;Rui Ning,&nbsp;Xun Chen,&nbsp;Xiaoying Wang","doi":"10.1016/j.aopr.2026.02.001","DOIUrl":"10.1016/j.aopr.2026.02.001","url":null,"abstract":"<div><h3>Purposes</h3><div>This study reports 15-year outcomes of implantable collamer lens (ICL) surgery in patients with high myopia, analyzing complications, efficacy of cataract surgical, and ultrastructural mechanisms of anterior subcapsular cataract (ASC).</div></div><div><h3>Methods</h3><div>This retrospective study included 1208 eyes (ICL V4) and 6258 eyes (ICL V4c) from Eye &amp; ENT Hospital of Fudan University, Shanghai, China. Follow-ups occurred preoperatively, at 1/3/6 months, annually post-ICL, and 1 month post-cataract surgery. Lens opacity, ASC rates, and complications were evaluated. Anterior capsule ultrastructure was assessed using scanning/transmission electron microscopy (SEM/TEM).</div></div><div><h3>Results</h3><div>The ICL V4 group (follow-up: 23.12 ± 32.06 months) exhibited higher complication rates than V4c (8.95 ± 17.40 months): lens opacity (6.46% vs. 0.16%), ASC (2.32% vs. 0.10%), and bilensectomy (3.89% vs. 0.16%). Bilensectomy improved corrected distance visual acuity from 0.56 ± 0.39 to 0.34 ± 0.51 logMAR (<em>P</em> = 0.006), restoring pre-ICL levels (<em>P</em> = 0.310), with safety/efficacy indices of 1.08 ± 0.11 and 0.99 ± 0.08. Myopia-related complications included myopic macular atrophy (0.38%), choroidal neovascularization (0.24%), and retinal detachment (0.04%). SEM/TEM revealed lens epithelial cell proliferation, fibronectin or collagen deposition, and mitochondrial abnormalities (thickened cristae, perinuclear vacuolization) in ASC cases.</div></div><div><h3>Conclusions</h3><div>Super high myopia, shallow anterior chamber depth, and older age are key risk factors for post-ICL cataract. While bilensectomy restores vision, high myopia-related complications persist. ASC pathogenesis involves mechanical damage and metabolic dysfunction, evidenced by ultrastructural changes. These findings underscore the need for long-term monitoring in ICL patients with high myopia.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"6 3","pages":"Pages 308-318"},"PeriodicalIF":4.5,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148951069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating micronutrients as protective factors for the retinal structure and vasculature: Mendelian randomization analyses 循环微量营养素作为视网膜结构和血管的保护因素:孟德尔随机化分析。
IF 4.5
Advances in ophthalmology practice and research Pub Date : 2026-08-01 Epub Date: 2026-03-12 DOI: 10.1016/j.aopr.2026.03.002
Linxin Wei, Meiqian He, Qing Zhao, Xinyu Zhao, Youxin Chen
{"title":"Circulating micronutrients as protective factors for the retinal structure and vasculature: Mendelian randomization analyses","authors":"Linxin Wei,&nbsp;Meiqian He,&nbsp;Qing Zhao,&nbsp;Xinyu Zhao,&nbsp;Youxin Chen","doi":"10.1016/j.aopr.2026.03.002","DOIUrl":"10.1016/j.aopr.2026.03.002","url":null,"abstract":"<div><h3>Background</h3><div>Epidemiological data and clinical trials have suggested that micronutrients may preserve retinal integrity by mitigating neurodegenerative alterations and microvascular damage. To strengthen the genetic evidence, we investigated the causal effects of various circulating micronutrients (CMs) on retinal imaging parameters using Mendelian randomization (MR) analyses.</div></div><div><h3>Methods</h3><div>Two-sample MR analyses utilized genetic variants as instrumental variables to investigate the effects of 14 CMs on retinal structural parameters including ganglion cell inner plexiform layer (GCIPL) thickness, outer nuclear layer thickness, and retinal nerve fiber layer thickness, as well as retinal vascular parameters comprising vascular density (VD) and fractal dimension (FD). Inverse variance weighted model was employed as the primary analytical method, with 5 sensitivity methods supplemented to confirm the results' robustness.</div></div><div><h3>Results</h3><div>Genetic predisposition to higher circulating folate levels was robustly associated with increased macular GCIPL thickness (<em>β</em>=0.94, 95% confidence interval (CI): 0.17–1.70, <em>P</em>=0.017), which remained significant (<em>P</em>=0.039) after MRlap correction. While nominal associations were observed between circulating vitamin B12 and vitamin E levels with both VD (vitamin B12: <em>β</em>=0.33, 95% CI: 0.09–0.56, <em>P</em>=0.007; vitamin E: <em>β</em>=0.19, 95% CI: 0.04–0.34, <em>P</em>=0.016) and FD (vitamin B12: <em>β</em>=0.24, 95% CI: 0.05−0.42, <em>P</em>=0.012; vitamin E: <em>β</em>=0.18, 95% CI: 0.04−0.33, <em>P</em>=0.016), these findings warranted a cautious interpretation due to inconsistencies across sensitivity analyses.</div></div><div><h3>Conclusions</h3><div>Our MR analyses evaluate the complex relationship between CMs and retinal imaging features, suggesting the protective and thus potentially therapeutic effects of folate in maintaining GCIPL thickness. Conversely, the potential associations observed for other micronutrients remain tentative and warrant cautious interpretation and further empirical validation.</div></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"6 3","pages":"Pages 237-246"},"PeriodicalIF":4.5,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13448425/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148690253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书